4.7 Review

Review: High-performance computing to detect epistasis in genome scale data sets

Journal

BRIEFINGS IN BIOINFORMATICS
Volume 17, Issue 3, Pages 368-379

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/bib/bbv058

Keywords

epistasis; SNP-interactions; high-performance computing; disease marker; biomarker; genome sequencing; genotyping

Funding

  1. Mr. SymBioMath IAPP [324554]
  2. Plataforma de Recursos Biomoleculares y Bioinformaticos [ISCIIIPT13.0001.0012]
  3. Proyecto de Excelencia Junta de Andalucia [P10-TIC-6108]
  4. Health Government of Andalusia [PI-0279-2012]
  5. Carlos III National Health Institute (RIRAAF Network) [RD12/0013]
  6. FIS [PI12/02247]
  7. Miguel Servet Program [CP14/00034]
  8. Sara Borrell Program [CD14/00242]

Ask authors/readers for more resources

It is becoming clear that most human diseases have a complex etiology that cannot be explained by single nucleotide polymorphisms (SNPs) or simple additive combinations; the general consensus is that they are caused by combinations of multiple genetic variations. The limited success of some genome-wide association studies is partly a result of this focus on single genetic markers. A more promising approach is to take into account epistasis, by considering the association of multiple SNP interactions with disease. However, as genomic data continues to grow in resolution, and genome and exome sequencing become more established, the number of combinations of variants to consider increases rapidly. Two potential solutions should be considered: the use of high-performance computing, which allows us to consider a larger number of variables, and heuristics to make the solution more tractable, essential in the case of genome sequencing. In this review, we look at different computational methods to analyse epistatic interactions within disease-related genetic data sets created by microarray technology. We also review efforts to use epistatic analysis results to produce biomarkers for diagnostic tests and give our views on future directions in this field in light of advances in sequencing technology and variants in non-coding regions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available